TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32569934

Group type: EXPERIMENTAL
Intervention: Fermented soybean (FS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-fermented soybean (NFS)
Number of subjects: 0
Study: 35883102

Group type: EXPERIMENTAL
Intervention: GRIPP intervention program (6 exercises, maximum total of 10 min)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Usual warm-up
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: GRIPP intervention program
Number of subjects: 308
Study: 32993637

Group type: EXPERIMENTAL
Intervention: EQ‐5D‐3L
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: EQ‐5D‐5L
Number of subjects: 224

Group type: COMPARATOR
Intervention: Barthel Index
Number of subjects: 224
Study: 36077145

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (200 µg or 8000 IU)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 33407848

Group type: EXPERIMENTAL
Intervention: Tailored Intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy and 30 days of 2-way text messaging
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard of Care (SOC) counseling
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tailored Intervention (TI)
Number of subjects: 25
Study: 616120584

Group type: EXPERIMENTAL
Intervention: UVA/riboflavin corneal collagen crosslinking (CXL)
Number of subjects: 44
Study: 35750731

Group type: EXPERIMENTAL
Intervention: Leaflet with visual aids
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Leaflet with no visual aids
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Verbal information only
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (leaflet with visual aids)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 99
Study: 34158786

Group type: EXPERIMENTAL
Intervention: Undiagnosed clinical depression
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Mild depression symptoms
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Non-adherence to antihypertensive medications (AHTNM)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Health-care system support
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Number of antihypertensive medications (AHTNM)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Better social support
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Stronger patient-doctor relationship
Number of subjects: 538
Study: 32265309

Group type: EXPERIMENTAL
Intervention: Inhaled Aztreonam
Number of subjects: 0
Study: 34210211

Group type: EXPERIMENTAL
Intervention: High-level construal task
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Low-level construal task
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Ambiguous health communication
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Unambiguous health communication
Number of subjects: 135
Study: 34315508

Group type: EXPERIMENTAL
Intervention: Proprioceptive training with Flexibar® (9 min daily for 12 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Proprioceptive training with Flexibar® (9 min daily for 12 weeks) and at least 40 min running or walking/week with XCO®
Number of subjects: 71
Study: 35809206

Group type: EXPERIMENTAL
Intervention: taVNS
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sham stimulation (SS)
Number of subjects: 124
Study: 35213109

Group type: EXPERIMENTAL
Intervention: Low‐Level Light Amplification by Stimulated Emission of Radiation therapy (LLLT) using Diode LASER
Number of subjects: 21

Group type: COMPARATOR
Intervention: Topical Anginovag spray medication
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conservative treatment with motivation and follow‐up
Number of subjects: 21
Study: 32145713

Group type: EXPERIMENTAL
Intervention: Non-intubated anaesthesia combined with paravertebral nerve block (PVNB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anaesthesia with tracheal intubation (control)
Number of subjects: 60
Study: 32519248

Group type: EXPERIMENTAL
Intervention: Patient with white collar occupation and secure attachment
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Patient exhibiting avoidant attachment behaviors
Number of subjects: 208
Study: 34792562

Group type: EXPERIMENTAL
Intervention: TNFi (infliximab)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: anti-IL-6 (tocilizumab)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: CTLA4-Ig (abatacept)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: anti-CD20 (rituximab)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TTV levels at month 3
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: TTV cut-off level of 1.2 × 10^6 c/ml at month 3
Number of subjects: 95
Study: 34062027

Group type: EXPERIMENTAL
Intervention: High-dose nebulized salbutamol (0.15 mg/kg 2–4 h intervals) with oral prednisolone (2 mg/kg/d for 3 days)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: On-demand inhaled salbutamol with oral prednisolone (2 mg/kg/d for 3 days)
Number of subjects: 95

Group type: COMPARATOR
Intervention: High-dose nebulized salbutamol (0.15 mg/kg 2–4 h intervals) with placebo
Number of subjects: 95

Group type: COMPARATOR
Intervention: On-demand inhaled salbutamol with placebo
Number of subjects: 95
Study: 32204977

Group type: EXPERIMENTAL
Intervention: Egg (low-carbohydrate protein-rich bedtime snack)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Yogurt (high-carbohydrate protein-rich bedtime snack)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No Bedtime Snack
Number of subjects: 15
Study: 35922816

Group type: EXPERIMENTAL
Intervention: rTMS (n=20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham (placebo; n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 30
Study: 32168067

Group type: EXPERIMENTAL
Intervention: Prednisolone (1 mg/kg per day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (matched)
Number of subjects: 37
Study: 35485186

Group type: EXPERIMENTAL
Intervention: Exercise plus Pain Neuroscience Education (PNE)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Exercise plus PNE
Number of subjects: 127
Study: 34788298

Group type: EXPERIMENTAL
Intervention: 5:2 self‐help instructions (5:2SH)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard Brief Advice (SBA)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 5:2 group support (5:2G)
Number of subjects: 300
Study: 32212089

Group type: EXPERIMENTAL
Intervention: Sorafenib plus Metformin (arm A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sorafenib alone (arm B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low VEGF and HIF‐1 α plasma levels
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High expressions of VEGF and HIF in HCC tissue
Number of subjects: 80
Study: 32402609

Group type: EXPERIMENTAL
Intervention: Remotely supervised cranial electrical stimulation (CES) for 10 daily sessions (60 min each) over two weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Remotely supervised cranial electrical stimulation (CES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham cranial electrical stimulation (CES)
Number of subjects: 30
Study: 35719338

Group type: EXPERIMENTAL
Intervention: High-dose VA therapy (amoxicillin 1 g t.i.d. and VPZ 20 mg b.i.d.)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Low-dose VA therapy (amoxicillin 1 g b.i.d. and VPZ 20 mg b.i.d.)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (H. pylori-negative patients)
Number of subjects: 119
Study: 35708885

Group type: EXPERIMENTAL
Intervention: Venetoclax 400 mg once-daily plus obinutuzumab
Number of subjects: 274
Study: 33759753

Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 0
Study: 34529293

Group type: EXPERIMENTAL
Intervention: Dance and yoga intervention (twice weekly for 8 months)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 121
Study: 32179906

Group type: EXPERIMENTAL
Intervention: Multimatrix mesalazine (combined dose groups, 2.4 or 4.8 g/day)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Multimatrix mesalazine
Number of subjects: 1300
Study: 35389428

Group type: EXPERIMENTAL
Intervention: Bevacizumab and Atezolizumab
Number of subjects: 40
Study: 33534047

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 40mg bid for 3 days followed by 20mg bid for 3 days
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 64
Study: 32452590

Group type: EXPERIMENTAL
Intervention: 23°C environment
Number of subjects: 20

Group type: COMPARATOR
Intervention: 26°C environment
Number of subjects: 20
Study: 35279972

Group type: EXPERIMENTAL
Intervention: LMA‐S
Number of subjects: 132

Group type: COMPARATOR
Intervention: ETT
Number of subjects: 132
Study: 34886746

Group type: EXPERIMENTAL
Intervention: Castor oil (60 mL)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sunflower oil (60 mL, placebo)
Number of subjects: 70
Study: 34605221

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (60%-70% HRR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low-intensity exercise (30%-40% HRR)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 19
Study: 32081302

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Functional testing
Number of subjects: 0
Study: 34937245

Group type: EXPERIMENTAL
Intervention: Low-concentration atropine (0.01%) eye drops
Number of subjects: 30
Study: 32060260

Group type: EXPERIMENTAL
Intervention: Genetic study on snoring
Number of subjects: 408000

Group type: COMPARATOR
Intervention: Polygenic scores (PGS) to predict recent snoring and probable obstructive sleep apnoea (OSA)
Number of subjects: 408000

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 408000
Study: 36412382

Group type: EXPERIMENTAL
Intervention: High tidal volume (HTV) ventilation, 12-15 mL/kg (group H)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low tidal volume (LTV) ventilation, 6-8 mL/kg (group L)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Comparison of HTV and LTV
Number of subjects: 56
Study: 32063059

Group type: EXPERIMENTAL
Intervention: Aprocitentan 10 mg
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Aprocitentan 25 mg
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Aprocitentan 50 mg
Number of subjects: 490

Group type: COMPARATOR
Intervention: Lisinopril 20 mg (positive control)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 490
Study: 35241124

Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simulated lumbar spinal manipulation (placebo)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pain intensity measured using the Numeric Pain Rating Scale
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patient's expectation measured using a Likert scale
Number of subjects: 80
Study: 34018433

Group type: EXPERIMENTAL
Intervention: ASD-PLD
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: TD-PLD
Number of subjects: 48

Group type: COMPARATOR
Intervention: ASD-Video
Number of subjects: 48

Group type: COMPARATOR
Intervention: TD-Video
Number of subjects: 48
Study: 34984488

Group type: EXPERIMENTAL
Intervention: Non-spherical polyvinyl alcohol (ns-PVA)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Calibrated hydrogel microspheres (Embozene)
Number of subjects: 84
Study: 32639545

Group type: EXPERIMENTAL
Intervention: Water-based povidone-iodine
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Alcohol-based povidone-iodine
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Alcohol-based chlorhexidine
Number of subjects: 661
Study: 33860839

Group type: EXPERIMENTAL
Intervention: Hearing aids (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no hearing aids)
Number of subjects: 0
Study: 34491022

Group type: EXPERIMENTAL
Intervention: aboBoNT‐A 50 U (5 injections of 0.1 mL each)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 33350959

Group type: EXPERIMENTAL
Intervention: Combined conventional and digital education through WhatsApp Messenger
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional oral health education
Number of subjects: 80
Study: 36325887

Group type: EXPERIMENTAL
Intervention: Disruptive Mood Dysregulation Disorder (DMDD)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Attention‐Deficit/Hyperactivity Disorder (ADHD)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Anxiety Disorder (ANX)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Healthy Volunteers
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Overall Sample
Number of subjects: 130
Study: 34270797

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg q2w (baseline weight < 60 kg)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg q2w (baseline weight ≥ 60 kg)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Dupilumab 100 mg q2w (baseline weight < 30 kg)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg q2w (baseline weight 30-< 60 kg)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg q4w (baseline weight ≥ 30 kg)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 618
Study: 32267205

Group type: EXPERIMENTAL
Intervention: Lower dose regimen (TDF 200 mg, efavirenz 400 mg, lamivudine 300 mg)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard dose regimen
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Lower dose regimen
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Lower dose regimen and Standard dose regimen
Number of subjects: 184
Study: 35562792

Group type: EXPERIMENTAL
Intervention: 8-week adapted mindfulness-based stress management program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study: 32348700

Group type: EXPERIMENTAL
Intervention: Combined screening and treatment program targeting psychological distress
Number of subjects: 349
Study: 35197490

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) sessions daily over five consecutive days
Number of subjects: 34
Study: 32525955

Group type: EXPERIMENTAL
Intervention: Simulation group (n = 11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 21
Study: 34269457

Group type: EXPERIMENTAL
Intervention: Parachute delivery of RBC concentrates (RCC) and whole blood (WB)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (storage under conventional conditions at 4 ± 2°C)
Number of subjects: 44
Study: 32532687

Group type: EXPERIMENTAL
Intervention: Salmonella typhi vaccine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo saline injection
Number of subjects: 20
Study: 36443929

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral‐theory‐based psychoeducation (CBT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neuromodulators (NMD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Proton pump inhibitor (PPI)
Number of subjects: 40
Study: 34402327

Group type: EXPERIMENTAL
Intervention: Bayesian Improved Surname Geocoding (BISG) algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: NJ‐SHO reported race/ethnicity values
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BISG probabilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BISG algorithm
Number of subjects: 0
Study: 32365303

Group type: EXPERIMENTAL
Intervention: MAL+FRU+PEC+ALG (16% maltodextrin+fructose+pectin‐alginate)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: MAL+FRU (16% maltodextrin+fructose)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study: 32703048

Group type: EXPERIMENTAL
Intervention: Nasal endoscope assisted suction cutter
Number of subjects: 82

Group type: COMPARATOR
Intervention: Small-cut trimming
Number of subjects: 82
Study: 32862421

Group type: EXPERIMENTAL
Intervention: Tobacco exposure
Number of subjects: 1826

Group type: COMPARATOR
Intervention: Control (non-tobacco users)
Number of subjects: 1826
Study: 36243742

Group type: EXPERIMENTAL
Intervention: Stress induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 34614061

Group type: EXPERIMENTAL
Intervention: Lithium disilicate onlays (IPS e.max CAD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Feldspathic ceramic onlays (Vita Mark II)
Number of subjects: 11
Study: 36107715

Group type: EXPERIMENTAL
Intervention: Dopamine D2/3 receptor availability (BPND) in people who smoke
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cognition assessment using the CogState battery (International Shopping List) in people who smoke
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy-controls (N=25)
Number of subjects: 24
Study: 32167794

Group type: EXPERIMENTAL
Intervention: Active acupuncture (AA group n = 48)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo acupuncture (PA group n = 48)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Active acupuncture (AA group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo acupuncture (PA group)
Number of subjects: 96
Study: 34003351

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (NCRT)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Baseline mrT3 substage, extramural venous invasion (EMVI) grading, mucinous adenocarcinoma, mesorectal fascia involvement, elevated pretreatment carcinoembryonic antigen level
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: T3 substage, EMVI grading, NCRT
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Nomograms constructed from baseline MRI characteristics
Number of subjects: 256
Study: 34278530

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 48
Study: 33686407

Group type: EXPERIMENTAL
Intervention: Standard 150 IU dose proposed by the OPTIMIST trial
Number of subjects: 2677

Group type: COMPARATOR
Intervention: Starting dose >300 IU
Number of subjects: 2677
Study: 32960920

Group type: EXPERIMENTAL
Intervention: Passive playing strategy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Active playing strategy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mixed playing strategy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (own strategy)
Number of subjects: 12
Study: 33712478

Group type: EXPERIMENTAL
Intervention: CLS-TA
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham-control
Number of subjects: 33
Study: 34652514

Group type: EXPERIMENTAL
Intervention: Optical CT‐free navigation (ExactechGPS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Acceleration‐based navigation (KneeAlign2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 45
Study: 35477876

Group type: EXPERIMENTAL
Intervention: App conditional feedback group (250 patients) using the medication reminder app for medication and BP check alarms.
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conventional treatment group (250 patients).
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: App conditional feedback group (250 patients).
Number of subjects: 500
Study: 33337995

Group type: EXPERIMENTAL
Intervention: Rheumatoid factor (RF) positive subjects
Number of subjects: 15907

Group type: EXPERIMENTAL
Intervention: Anti-citrullinated peptide antibodies (ACPA) positive subjects
Number of subjects: 15907

Group type: EXPERIMENTAL
Intervention: 15-year risk of developing rheumatoid arthritis (RA)
Number of subjects: 15907

Group type: EXPERIMENTAL
Intervention: Relative risk for developing RA associated with RF
Number of subjects: 15907

Group type: EXPERIMENTAL
Intervention: Relative risk for developing RA associated with ACPA
Number of subjects: 15907
Study: 33200282

Group type: COMPARATOR
Intervention: 37% phosphoric acid (SD-CT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid with 2% chlorhexidine (CAD-CHX)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10% phosphoric acid with 2% grape seed extract (CAD-GSE)
Number of subjects: 32
Study: 32015212

Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse (CMR; 6% dextrose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 35838130

Group type: EXPERIMENTAL
Intervention: Bipolar Needlescopic Enucleation of the Prostate (BNEP)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Bipolar Vapoenucleation of the Prostate (BVEP)
Number of subjects: 214
Study: 35602281

Group type: EXPERIMENTAL
Intervention: Septoplasty
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nonsurgical management
Number of subjects: 140
Study: 33399175

Group type: EXPERIMENTAL
Intervention: Maitland therapy (central or unilateral postero‐anterior pressure) for 2 sessions/week for 3 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Mulligan sustained natural apophyseal glides for 2 sessions/week for 3 weeks
Number of subjects: 44
Study: 34059737

Group type: EXPERIMENTAL
Intervention: Program B (fixed-order, internet cognitive behavioral therapy, iCBT)
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Program A (free-choice, multimodule stress management)
Number of subjects: 951

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 951
Study: 32029495

Group type: EXPERIMENTAL
Intervention: nal-IRI/5-FU/folinic acid
Number of subjects: 102

Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 102